F Pietrantonio Selected Research

Pseudomyxoma Peritonei

11/2016

Toward the molecular dissection of peritoneal pseudomyxoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Pietrantonio Research Topics

Disease

16	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 10/2012
11	Neoplasms (Cancer) 04/2024 - 01/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 01/2014
2	Breast Neoplasms (Breast Cancer) 12/2018 - 12/2016
1	Constipation 10/2023
1	Diarrhea 10/2023
1	Exanthema (Rash) 10/2023
1	Hypothyroidism 10/2023
1	Nausea 10/2023
1	Rectal Neoplasms (Rectal Cancer) 10/2023
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Neutropenia 12/2021
1	Febrile Neutropenia 12/2021
1	Microsatellite Instability 01/2021
1	Melanoma (Melanoma, Malignant) 12/2018
1	Obesity 01/2017
1	Thromboembolism 01/2017
1	Pseudomyxoma Peritonei 11/2016
1	Glioblastoma (Glioblastoma Multiforme) 09/2015
1	Carcinogenesis 01/2014

Drug/Important Bio-Agent (IBA)

4	Cetuximab (Erbitux)FDA Link 04/2024 - 10/2012
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 07/2013
4	Bevacizumab (Avastin)FDA Link 12/2022 - 10/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2017
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 07/2013
3	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 02/2014
2	trifluridine tipiracil drug combinationIBA 04/2024 - 01/2017
2	regorafenibIBA 04/2024 - 01/2017
2	Leucovorin (Folinic Acid)FDA Link 12/2021 - 07/2013
1	encorafenibIBA 04/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024
1	Capecitabine (Xeloda)FDA Link 10/2023
1	durvalumabIBA 10/2023
1	Transaminases (Aminotransferases)IBA 10/2023
1	Lipase (Acid Lipase)FDA Link 10/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	avelumabIBA 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	Estrogens (Estrogen)FDA Link 12/2018
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Immune Checkpoint InhibitorsIBA 12/2018
1	MethyltransferasesIBA 01/2018
1	Monoclonal AntibodiesIBA 12/2017
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2017
1	Prothrombin (Factor II)IBA 01/2017
1	Plasminogen Activator Inhibitor 1IBA 01/2017
1	Factor V (Coagulation Factor V)IBA 01/2017
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 12/2016
1	Codon (Codons)IBA 10/2015
1	Calcibiotic Root Canal SealerIBA 10/2015
1	Alkylating AgentsIBA 09/2015
1	Dacarbazine (DIC)FDA LinkGeneric 09/2015
1	Cell-Free Nucleic AcidsIBA 09/2015
1	TegafurIBA 06/2014
1	UracilIBA 06/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 07/2013

Therapy/Procedure

8	Therapeutics 04/2024 - 01/2014
8	Drug Therapy (Chemotherapy) 04/2024 - 07/2013
3	Immunotherapy 01/2022 - 12/2018
1	Neoadjuvant Therapy 10/2023
1	Chemoradiotherapy 10/2023
1	Continuity of Patient Care 06/2023
1	Combination Drug Therapy (Combination Chemotherapy) 10/2021
1	Radiotherapy 12/2018
1	Salvage Therapy 01/2018
1	Duration of Therapy 01/2017
1	Hyperthermic Intraperitoneal Chemotherapy 11/2016
1	Cytoreduction Surgical Procedures 11/2016